Cargando…

28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts

Detalles Bibliográficos
Autores principales:	Murphy, William, Klebanov, Nikolai, Pahalyants, Vartan, Theodosakis, Nicholas, Patel, Kevin, Klevens, R. Monina, Lilly, Evelyn, Semenov, Yevgeniy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349151/ http://dx.doi.org/10.1016/j.jaad.2021.06.820

Ejemplares similares

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
por: Pahalyants, Vartan, et al.
Publicado: (2022)

28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study
por: Pahalyants, Vartan, et al.
Publicado: (2021)

27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study
por: Klebanov, Nikolai, et al.
Publicado: (2021)

028 Use of systemic immunosuppressive treatment is not related to COVID-19 infection in a retrospective review of patients in Massachusetts
por: Murphy, W., et al.
Publicado: (2021)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Klebanov, Nikolai, et al.
Publicado: (2021)

336 Risks of COVID-19 infection and mortality for patients on biologics
por: Pahalyants, V., et al.
Publicado: (2021)

Massachusetts flu vaccination and application for COVID-19 routine vaccination planning
por: Hatch, Megan, et al.
Publicado: (2022)

The Massachusetts Hepatitis C Testing Cascade, 2014-2016
por: Vo, Quynh T, et al.
Publicado: (2019)

Outpatient Antibiotic Prescribing in Massachusetts, 2011–2015
por: Klevens, R Monina, et al.
Publicado: (2019)

283. Population-Based Co-infection of Carbapenem-Resistant Organisms and SARS-CoV-2 in Massachusetts
por: Geoghegan, Ashley, et al.
Publicado: (2021)

The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts
por: Gonsalves, Gregg S, et al.
Publicado: (2021)

Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
por: Tiu, Bruce C, et al.
Publicado: (2022)

Linking Epidemiology and Whole-Genome Sequencing to Investigate Salmonella Outbreak, Massachusetts, USA, 2018
por: Vaughn, Eric L., et al.
Publicado: (2020)

Influence of geospatial resolution on sociodemographic predictors of COVID-19 in Massachusetts
por: Patil, Prasad, et al.
Publicado: (2023)

Missing Race and Ethnicity Data among COVID-19 Cases in Massachusetts
por: Spangler, Keith R., et al.
Publicado: (2022)

Chlamydia Treatment Practices and Time to Treatment in Massachusetts: Directly Observed Therapy Versus Pharmacy Prescriptions
por: Platt, Laura, et al.
Publicado: (2021)

28561 The impact of telemedicine on the delivery of dermatologic care during the COVID-19 pandemic
por: Pahalyants, Vartan, et al.
Publicado: (2021)

Community predictors of COVID‐19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data
por: Spangler, Keith R., et al.
Publicado: (2021)

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
por: Kalinich, Mark, et al.
Publicado: (2021)

Surveillance and Seroepidemiology
por: Jiles, Ruth, et al.
Publicado: (2014)

Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens
por: Ma, Kevin C, et al.
Publicado: (2022)

Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003–2006 and 2007–2010
por: Kruszon-Moran, Deanna, et al.
Publicado: (2013)

Vital Signs: Evaluation of Hepatitis C Virus Infection Testing and Reporting — Eight U.S. Sites, 2005–2011
por: Bornschlegel, Katherine, et al.
Publicado: (2013)

Rapidly progressive squamous cell carcinoma in a patient with longstanding history of folliculitis decalvans
por: Pahalyants, Vartan, et al.
Publicado: (2021)

1151 Geographic Distances Between Patients and Providers for Hepatitis C Virus Infection Testing
por: Klevens, Monina, et al.
Publicado: (2014)

Syndrome Development to Assess IDU, HIV, and Homelessness in MA Emergency Departments
por: Albert, Stefanie P., et al.
Publicado: (2019)

Massachusetts
Publicado: (1896)

Massachusetts
por: Rogers, Howard P.
Publicado: (1896)

Massachusetts
Publicado: (1896)

Massachusetts
Publicado: (1896)

Massachusetts
por: Lewis, H. S.
Publicado: (1899)

Massachusetts
Publicado: (1896)

Massachusetts
Publicado: (1896)

Massachusetts
Publicado: (1896)

Massachusetts
Publicado: (1895)

Massachusetts
Publicado: (1895)

Massachusetts
Publicado: (1895)

Massachusetts
Publicado: (1897)

The Use of the International Classification of Diseases, Ninth Revision (ICD-9) Coding in Identifying Chronic Hepatitis B Virus Infection in Health System Data: Implications for Surveillance
por: Mahajan, Reena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kthhu78mlvhd5n1qp945kmbpm3